UNSPSC 51372009: Hydromorphinol

This classification denotes an opioid receptor agonist with the molecular formula C17H21NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1O00P9X5C1, chemically known as morphinan-3,6,14-triol, 4,5-epoxy-17-methyl-, (5.alpha.,6.beta.)- but generally known as hydromorphinol, which bears US NIH Compound Identifier 627484. European Medicines Agency schedules Hydromorphinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08069MIG. The term HYDROMORPHINOL is an International Non-Proprietary Name.

UNSPSC 51372009 Hydromorphinol is a Commodity code that maps to pharmaceutical procurement, though recent state and local solicitations under this code show limited activity and do not align clearly with the code's pharmaceutical focus. The single recent opportunity tagged to this code is Seminole County, Florida's IFB for Naloxone and Safe Drug Deactivation Systems, which represents public health emergency-response procurement rather than hydromorphinol acquisition. The mismatch suggests either a classification error in the county's tagging or that the code is used inconsistently in state and local procurement systems. When opportunities do appear under this code, they reflect county health departments' acquisition of critical pharmaceutical or medical countermeasures for community health initiatives.

Seminole County, Florida, posted IFB 60459723LAS on June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding. Quarterly deliveries were required to the Seminole County Community Health Building in Sanford, Florida; vendors were responsible for all shipping and delivery costs and had to comply with drug-free workplace certification, E-Verify requirements, and specific insurance coverages. The contract included an initial two-year term with a one-year renewal option and was potentially funded through FEMA. This code shows minimal recent state and local procurement activity, and the available opportunity reflects emergency-response pharmaceutical procurement rather than the code's nominal scope. Firms evaluating this code should confirm proper UNSPSC classification with issuers before pursuing opportunities.